Reduced expression of HLA class II molecules and Iinterleukin-10- and transforming growth factor beta1-independent suppression of T-cell proliferation in human cytomegalovirus-infected macrophage cultures
- PMID: 11333898
- PMCID: PMC114922
- DOI: 10.1128/JVI.75.11.5174-5181.2001
Reduced expression of HLA class II molecules and Iinterleukin-10- and transforming growth factor beta1-independent suppression of T-cell proliferation in human cytomegalovirus-infected macrophage cultures
Abstract
After a primary infection, human cytomegalovirus (HCMV) establishes lifelong latency in myeloid lineage cells, and the virus has developed several mechanisms to avoid immune recognition and destruction of infected cells. In this study, we show that HCMV utilizes two different strategies to reduce the constitutive expression of HLA-DR, -DP, and -DQ on infected macrophages and that infected macrophages are unable to stimulate a specific CD4+ T-cell response. Downregulation of the HLA class II molecules was observed in 90% of the donor samples and occurred in two phases: at an early (1 day postinfection [dpi]) time point postinfection and at a late (4 dpi) time point postinfection. The early inhibition of HLA class II expression and antigen presentation was not dependent on active virus replication, since UV-inactivated virus induced downregulation of HLA-DR and inhibition of T-cell proliferation at 1 dpi. In contrast, the late effect required virus replication and was dependent on the expression of the HCMV unique short (US) genes US1 to -9 or US11 in 77% of the samples. HCMV-treated macrophages were completely devoid of T-cell stimulation capacity at 1 and 4 dpi. However, while downregulation of HLA class II expression was rather mild, a 66 to 90% reduction in proliferative T-cell response was observed. This discrepancy was due to undefined soluble factors produced in HCMV-infected cell cultures, which did not include interleukin-10 and transforming growth factor beta1. These results suggest that HCMV reduces expression of HLA class II molecules on HCMV-infected macrophages and inhibits T-cell proliferation by different distinct pathways.
Figures
Similar articles
-
Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells.Nat Med. 1999 Sep;5(9):1039-43. doi: 10.1038/12478. Nat Med. 1999. PMID: 10470081
-
Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.J Immunol. 1986 Jul 15;137(2):400-7. J Immunol. 1986. PMID: 2941479
-
Macrophage cultures are susceptible to lytic productive infection by endothelial-cell-propagated human cytomegalovirus strains and present viral IE1 protein to CD4+ T cells despite late downregulation of MHC class II molecules.J Gen Virol. 2006 Jul;87(Pt 7):1853-1862. doi: 10.1099/vir.0.81595-0. J Gen Virol. 2006. PMID: 16760387
-
Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.Curr Top Microbiol Immunol. 2002;269:101-15. doi: 10.1007/978-3-642-59421-2_7. Curr Top Microbiol Immunol. 2002. PMID: 12224504 Review.
-
A Review of the Potential Role of Human Cytomegalovirus (HCMV) Infections in Breast Cancer Carcinogenesis and Abnormal Immunity.Cancers (Basel). 2019 Nov 22;11(12):1842. doi: 10.3390/cancers11121842. Cancers (Basel). 2019. PMID: 31766600 Free PMC article. Review.
Cited by
-
Herpesviruses placating the unwilling host: manipulation of the MHC class II antigen presentation pathway.Viruses. 2012 Aug;4(8):1335-53. doi: 10.3390/v4081335. Epub 2012 Aug 22. Viruses. 2012. PMID: 23012630 Free PMC article. Review.
-
Adult and Cord Blood-Derived High-Affinity gB-CAR-T Cells Effectively React Against Human Cytomegalovirus Infections.Hum Gene Ther. 2020 Apr;31(7-8):423-439. doi: 10.1089/hum.2019.149. Hum Gene Ther. 2020. PMID: 32159399 Free PMC article.
-
Human cytomegalovirus decreases constitutive transcription of MHC class II genes in mature Langerhans cells by reducing CIITA transcript levels.Mol Immunol. 2011 May;48(9-10):1160-7. doi: 10.1016/j.molimm.2011.02.010. Epub 2011 Mar 31. Mol Immunol. 2011. PMID: 21458073 Free PMC article.
-
Cytomegalovirus immune evasion by perturbation of endosomal trafficking.Cell Mol Immunol. 2015 Mar;12(2):154-69. doi: 10.1038/cmi.2014.85. Epub 2014 Sep 29. Cell Mol Immunol. 2015. PMID: 25263490 Free PMC article. Review.
-
Mismatched unrelated donors allogeneic hematopoietic stem cell transplantation with antithymocyte globulin for hematological malignancies: a multicenter retrospective study in China.Bone Marrow Transplant. 2024 Nov 8. doi: 10.1038/s41409-024-02454-5. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 39516707
References
-
- Ahlfors K. IgG antibodies to cytomegalovirus in a normal urban Swedish population. Scand J Infect Dis. 1984;16:335–337. - PubMed
-
- Ahn K, Gruhler A, Galocha B, Jones T R, Wiertz E J, Ploegh H L, Peterson P A, Yang Y, Fruh K. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity. 1997;6:613–621. - PubMed
-
- Boss J M. Regulation of transcription of MHC class II genes. Curr Opin Immunol. 1997;9:107–113. - PubMed
-
- Cerboni C, Mousavi-Jazi M, Linde A, Söderström K, Brytting M, Wahren B, Kärre K, Carbone E. Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts. J Immunol. 2000;164:4775–4782. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials